Verisk Health appoints Emad Rizk as CEO
Dr. Emad Rizk is a seasoned and renowned healthcare industry senior executive with over 25 years of experience working closely with Payers and Government entities.
Dr. Rizk joins Verisk Health from Accretive Health, Inc. where he served as CEO and as a member of its Board of Directors.
Prior to Accretive Health, he was President at McKesson Health Solutions, a business that provides clinical and financial solutions to most of the Healthcare Payers. He is also a regular lecturer at Wharton, Harvard, MIT, Columbia, and Kellogg.
Before joining McKesson (MCK), Dr. Rizk served as Senior Partner and Global Director, Medical Management/Pharmacy for Deloitte Consulting. While at Deloitte, he led the company’s medical cost and quality management practice across all segments.
Prior to that, Dr. Emad served as the Associate Medical Director and then Worldwide Medical Director at the Monsanto Corporation. He currently serves as a board member at Intarcia, Accuray, and the National Association for Hispanic Health.
He also previously served on the National Clinical Advisory Board, National Quality Review Board, and was Director on the board of DMAA (The Care Continuum Alliance). ■
LATEST MOVES FROM Massachusetts
- Dunkin' Brands Group appoints Linda Boff to board
- BayCoast Bank appoints Matthew Flanagan as vice president
- Endurance International Group appoints Marc Montagner as interim COO
- AVEO Oncology appoints Matthew Dallas as CFO
- Radius Health appoints Jose Pepe Carmona as CFO
More inside POST
AMD Q1 net loss $73 million Earnings